Exploring ecological modelling to investigate factors governing the colonization success in nosocomial environment of Candida albicans and other pathogenic yeasts
- PMID: 27246511
- PMCID: PMC4887984
- DOI: 10.1038/srep26860
Exploring ecological modelling to investigate factors governing the colonization success in nosocomial environment of Candida albicans and other pathogenic yeasts
Abstract
Two hundred seventy seven strains from eleven opportunistic species of the genus Candida, isolated from two Italian hospitals, were identified and analyzed for their ability to form biofilm in laboratory conditions. The majority of Candida albicans strains formed biofilm while among the NCAC species there were different level of biofilm forming ability, in accordance with the current literature. The relation between the variables considered, i.e. the departments and the hospitals or the species and their ability to form biofilm, was tested with the assessment of the probability associated to each combination. Species and biofilm forming ability appeared to be distributed almost randomly, although some combinations suggest a potential preference of some species or of biofilm forming strains for specific wards. On the contrary, the relation between biofilm formation and species isolation frequency was highly significant (R(2) around 0.98). Interestingly, the regression analyses carried out on the data of the two hospitals separately were rather different and the analysis on the data merged together gave a much lower correlation. These findings suggest that, harsh environments shape the composition of microbial species significantly and that each environment should be considered per se to avoid less significant statistical treatments.
Conflict of interest statement
In the past 2 years, Dr. Carlo Tascini has been paid for lectures on behalf of Pfizer, Novartis, Merck Astra, Angelini, Gilead and Astellas.
Figures
Similar articles
-
Yeasts isolated from nosocomial urinary infections: antifungal susceptibility and biofilm production.Rev Iberoam Micol. 2014 Apr-Jun;31(2):104-8. doi: 10.1016/j.riam.2013.06.004. Epub 2013 Jun 25. Rev Iberoam Micol. 2014. PMID: 23810785
-
Variation in biofilm formation among blood and oral isolates of Candida albicans and Candida dubliniensis.Enferm Infecc Microbiol Clin. 2011 Nov;29(9):660-5. doi: 10.1016/j.eimc.2011.06.009. Epub 2011 Sep 6. Enferm Infecc Microbiol Clin. 2011. PMID: 21899928
-
Multi-species biofilm of Candida albicans and non-Candida albicans Candida species on acrylic substrate.J Appl Oral Sci. 2012 Feb;20(1):70-5. doi: 10.1590/s1678-77572012000100013. J Appl Oral Sci. 2012. PMID: 22437681 Free PMC article.
-
Candida species: new insights into biofilm formation.Future Microbiol. 2012 Jun;7(6):755-71. doi: 10.2217/fmb.12.48. Future Microbiol. 2012. PMID: 22702528 Review.
-
Candida biofilms and their role in infection.Trends Microbiol. 2003 Jan;11(1):30-6. doi: 10.1016/s0966-842x(02)00002-1. Trends Microbiol. 2003. PMID: 12526852 Review.
Cited by
-
Merging FT-IR and NGS for simultaneous phenotypic and genotypic identification of pathogenic Candida species.PLoS One. 2017 Dec 4;12(12):e0188104. doi: 10.1371/journal.pone.0188104. eCollection 2017. PLoS One. 2017. PMID: 29206226 Free PMC article.
-
Exploring Sertoli Cells' Innate Bulwark Role Against Infections: In Vitro Performances on Candida tropicalis Biofilms.Cells. 2025 Mar 26;14(7):495. doi: 10.3390/cells14070495. Cells. 2025. PMID: 40214449 Free PMC article.
-
Echinocandins for management of invasive candidiasis in patients with liver disease and liver transplantation.Infect Drug Resist. 2018 May 30;11:805-819. doi: 10.2147/IDR.S165676. eCollection 2018. Infect Drug Resist. 2018. PMID: 29881298 Free PMC article. Review.
-
Black phosphorus/silk fibroin films hamper filamentous and invasive growth of Candida albicans.RSC Adv. 2024 Dec 11;14(53):39112-39121. doi: 10.1039/d4ra05126b. eCollection 2024 Dec 10. RSC Adv. 2024. PMID: 39664243 Free PMC article.
-
The Bovhyaluronidase Azoximer (Longidaza®) Disrupts Candida albicans and Candida albicans-Bacterial Mixed Biofilms and Increases the Efficacy of Antifungals.Medicina (Kaunas). 2022 Nov 23;58(12):1710. doi: 10.3390/medicina58121710. Medicina (Kaunas). 2022. PMID: 36556912 Free PMC article.
References
-
- Wisplinghoff H. et al. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clinical infectious diseases 39, 309–317 (2004). - PubMed
-
- Horn D. L. et al. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. Clinical infectious diseases 48, 1695–1703 (2009). - PubMed
-
- Sobel J. D. The emergence of non-albicans Candida species as causes of invasive candidiasis and candidemia. Current infectious disease reports 8, 427–433 (2006). - PubMed
-
- Dimopoulos G., Ntziora F., Rachiotis G., Armaganidis A. & Falagas M. E. Candida albicans versus non-albicans intensive care unit-acquired bloodstream infections: differences in risk factors and outcome. Anesthesia & Analgesia 106, 523–529 (2008). - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical